FIRST AMENDMENT TO OFFICE LEASE AGREEMENTOffice Lease Agreement • March 14th, 2023 • Clearside Biomedical, Inc. • Pharmaceutical preparations
Contract Type FiledMarch 14th, 2023 Company Industrymade and entered into effective as of the 1st day of November, 2022, by and between RADIANT-NORTH POINT PROPERTIES, LLLP, a Delaware limited liability limited partnership (as "Landlord"), and CLEARSIDE BIOMEDICAL, INC., a Delaware corporation (as "Tenant").
AMENDMENT NO. 1 TO THE OPTION AND LICENSE AGREEMENTOption and License Agreement • March 14th, 2023 • Clearside Biomedical, Inc. • Pharmaceutical preparations
Contract Type FiledMarch 14th, 2023 Company IndustryThis Amendment No. 1 (the “Amendment”) dated January 14, 2023 (“Amendment Effective Date”) is made by and between Clearside Biomedical, Inc., a Delaware corporation (“Clearside”) and REGENXBIO Inc., a Delaware corporation (“REGENXBIO”). Clearside and REGENXBIO may each be referred to herein individually as a “Party” and collectively as the “Parties.”